Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis

Published:2017-02 Issue:2 Volume:31 Page:286-299
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Gardner Eric E.,Lok Benjamin H.,Schneeberger Valentina E.,Desmeules Patrice,Miles Linde A.,Arnold Paige K.,Ni Andy,Khodos Inna,de Stanchina Elisa,Nguyen Thuyen,Sage Julien,Campbell John E.,Ribich Scott,Rekhtman Natasha,Dowlati Afshin,Massion Pierre P.,Rudin Charles M.,Poirier John T.

Funder

LUNGevity Foundation

American Lung Association

Free To Breathe

MSKCC

Conquer Cancer Foundation of ASCO

Radiological Society of North America

NIH

VA Merit review

Van Andel Research Institute

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference45 articles.

1. Signatures of mutational processes in human cancer;Alexandrov;Nature,2013

2. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity;Barretina;Nature,2012

3. Different levels of Twist1 regulate skin tumor initiation, stemness, and progression;Beck;Cell Stem Cell,2015

4. Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1508);Belani;Cancer,2016

5. Establishment and identification of small cell lung cancer cell lines having classic and variant features;Carney;Cancer Res.,1985

Cited by 392 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SLFN11 and ATR as targets for overcoming cisplatin resistance in ovarian cancer cells;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-12

2. Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer;Cancer Research Communications;2024-09-01

3. Immunohistochemical Evaluation of Schlafen 11 (SLFN11) Expression in Cancer in the Search of Biomarker-Informed Treatment Targets;American Journal of Surgical Pathology;2024-08-26

4. CDK4/6 Inhibitors Impede Chemoresistance and Inhibit Tumor Growth of Small Cell Lung Cancer;Advanced Science;2024-08-13

5. Overcoming resistance in small-cell lung cancer;Expert Review of Respiratory Medicine;2024-08-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3